S02E49- Dr. Ben Sessa, Psychedelics The Great Disruptors

Welcome to Episode 49 of The Mindfulness Experience Podcast

Hello and welcome to Episode 49 of The Mindfulness Experience Podcast, where we delve into mindfulness, personal growth, and transformation. I'm your host, Keith Fiveson, and today we have an extraordinary guest joining us – Dr. Ben Sessa, who provides us with incredible insight and brilliance as we look at Psychedelics The Great Disruptors.

Dr. Ben Sessa has been a trailblazer in psychedelic and cannabis research and clinical medicine in the UK through his affiliations with Imperial College London. A medical doctor specializing in psychiatry, Ben has over 25 years of experience as a consultant child and adolescent psychiatrist, working with young people and adult patients in addictions and trauma-related psychiatry.

As one of the pioneers in contemporary psychedelic research in the UK, Ben has participated in research projects at Bristol University, Cardiff University, and Imperial College London, studying compounds such as LSD, psilocybin, DMT, ketamine, and MDMA. He co-founded Awaken Life Sciences, a biotech company carrying out psychedelic research into addictions, and helped establish multiple high street clinics providing psychedelic psychotherapy throughout the UK and Europe.

In this episode, we will explore Dr. Sessa's incredible journey, his groundbreaking work in psychedelic research, and his role as one of the first medical cannabis psychiatric prescribers in the UK. We'll discuss his experiences as a trained MDMA, ketamine, and psilocybin therapist and his leadership in MDMA-assisted therapy training in Australia.  

You can link to his website here: http://www.drsessa.com/